Compare QURE & NHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QURE | NHC |
|---|---|---|
| Founded | 1998 | 1971 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2013 | 1997 |
| Metric | QURE | NHC |
|---|---|---|
| Price | $22.42 | $236.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $61.24 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 78.4K |
| Earning Date | 11-09-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 1.10% |
| EPS Growth | ★ 29.67 | 17.46 |
| EPS | N/A | ★ 4.82 |
| Revenue | $13,107,000.00 | ★ $1,517,781,000.00 |
| Revenue This Year | $54.78 | N/A |
| Revenue Next Year | $356.14 | N/A |
| P/E Ratio | ★ N/A | $50.38 |
| Revenue Growth | N/A | ★ 16.09 |
| 52 Week Low | $8.73 | $118.14 |
| 52 Week High | $71.50 | $248.20 |
| Indicator | QURE | NHC |
|---|---|---|
| Relative Strength Index (RSI) | 28.08 | 53.97 |
| Support Level | $22.32 | $216.83 |
| Resistance Level | $25.61 | N/A |
| Average True Range (ATR) | 1.19 | 7.31 |
| MACD | 0.75 | 0.75 |
| Stochastic Oscillator | 57.58 | 60.36 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.